太原屁股脓肿太原肛门 息肉,太原痔疮手术严重吗,山西痔疮特点,太原内痣,山西早期痔疮症状有哪些,山西看痔疮去什么医院,山西大便时拉血

The Trump administration is considering a new travel ban to replace its original executive order, which has had its legality questioned and is up for a Supreme Court hearing next month, White House national security adviser H.R. McMaster said Sunday."Well, this is something that we're looking at, is how to protect the American people better, how to ensure that we know who these people are who are moving," McMaster told George Stephanopoulos on ABC's "This Week."This renewed discussion of the travel ban comes after Friday morning's terrorist attack in London, in which 30 passengers on a London Underground train were injured after a bomb went off.In a tweet Friday in response to the attack, President Donald Trump called for a "larger, tougher and more specific" travel ban and also called for shutting down terrorist group's use of the internet for indoctrination and recruitment.McMaster echoed the point Sunday."Because of the strength of these terrorist organizations -- why this is a greater danger than ever -- is, first of all, their ability to communicate, to connect what would otherwise be disconnected cells in other places in the world," he said. "The second part of this is their ability to travel and to move and to move people and money and weapons, oftentimes drugs and other illicit goods, internationally. So part of the strategy must be to interdict these networks, interdict them from how they use information, and communicate, but how they move physically, as well.The Supreme Court is set to hear?oral arguments in the travel ban case early next month.The President's executive order would suspend travel from six Muslim-majority countries (Iran, Libya, Somalia, Sudan, Syria and Yemen) for 90 days while the secretary of homeland security and others submit a report on the results of a worldwide review to identify what additional information will be needed from each country to make sure an individual seeking entrance is not a public-safety threat.Responding to a lawsuits from states challenging the ban, the Supreme Court let much of the ban take effect in late June, meaning the 90-day clock started and will hit on or around September 24.Administration officials have not divulged the specifics of their future plans.At a recent homeland security conference in Washington DC, acting Customs and Border Protection Deputy Commissioner Ronald Vitiello said, "We are in the process of action planning about each of the opportunities that the US government has to interview and/or vet potential inbound travelers."That could include "looking at things like social media, looking at things like smart phones, those kinds of windows, if you will, into people's backgrounds and their activity," he said.The-CNN-Wire 2771

The US surgeon general issued an advisory Thursday recommending that more Americans carry the opioid overdose-reversing drug, naloxone.The drug, commonly known as Narcan, can very quickly restore normal breathing in someone suspected of overdosing on opioids, including heroin and prescription pain medications.Dr. Jerome Adams emphasized that "knowing how to use naloxone and keeping it within reach can save a life." To make his point, Adams relied on a rarely used tool: the surgeon general's advisory. The last such advisory was issued more than a decade ago and focused on drinking during pregnancy.Adams noted that the number of overdose deaths from prescription and illicit opioids doubled in recent years: from 21,089 deaths across the nation in 2010 to 42,249 in 2016.America's top doctor attributed this "steep increase" to several contributing factors, including "the rapid proliferation of illicitly made fentanyl and other highly potent synthetic opioids" and "an increasing number of individuals receiving higher doses of prescription opioids for long-term management of chronic pain.""Research shows that when naloxone and overdose education are available to community members, overdose deaths decrease in those communities," Adams said. Naloxone is used by police officers, first responders and emergency medical techs to reverse opioid overdoses. Adams added that increasing both the availability of naloxone and effective treatment is critical to ending the opioid epidemic.Speaking at the National Prescription Drug Abuse & Heroin Summit in Atlanta on Thursday morning, Adams addressed the potential "moral conflict" felt by some people who believe that providing naloxone "doesn't make a difference," since many people with drug addictions will just "go on and misuse substances again.""Well, that would be like me saying 'I'm not gonna go do surgery on this trauma patient because they're just gonna go out and speed again,' " he said.Adams noted that in most states, people who are or who know someone at risk for opioid overdose can get trained to use naloxone properly and also may receive naloxone by "standing order" -- without a prescription -- from pharmacies or some community-based programs."No mother should have to bury their child ,and especially not when there's a life-saving medication that virtually anyone can access," Adams said. "It is for this reason that I am issuing the first Surgeon General's Advisory in 13 years."The-CNN-Wire 2484

The US Food and Drug Administration approved two cancer treatments, Vitrakvi and Xospata, this week after expedited reviews.Vitrakvi, approved Monday, is "a treatment for adult and pediatric patients whose cancers have a specific genetic feature (biomarker)."The FDA said in a statement that it is the second approved cancer treatment that is based on a tumor biomarker instead of the place in the body where the tumor originated.Vitrakvi will be used for the treatment of solid tumors that have an NTRK (neurotrophic receptor tyrosine kinase) gene fusion that do not have a known resistance mutation, that are not metastatic or where surgical removal is likely to lead to severe morbidity, and that have no alternative treatments or have progressed after treatments.NTRK genes are rare but occur in many types of cancer, the FDA said, such as mammary analogue secretory carcinoma and infantile fibrosarcoma.Xospata tablets, approved Wednesday, are for the "treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation," according to the FDA.Alongside the tablets, the agency also approved a diagnostic to detect the mutation."Approximately 25 to 30 percent of patients with AML have a mutation in the FLT3 gene. These mutations are associated with a particularly aggressive form of the disease and a higher risk of relapse," Dr. Richard Pazdur, director of the FDA's Oncology Center of Excellence, said in the statement.AML is a rapidly progressing cancer that affects the numbers of normal blood cells and calls for continuous transfusions, the FDA said.Both treatments were granted Priority Review designation.Priority Review, established in 1992, means the FDA aims to review the drug or treatment within six months, opposed to 10 months for a standard review."A Priority Review designation will direct overall attention and resources to the evaluation of applications for drugs that, if approved, would be significant improvements in the safety or effectiveness of the treatment, diagnosis, or prevention of serious conditions when compared to standard applications," the FDA says.Both treatments also received?orphan drug?designation, a status granted to drugs for rare diseases or conditions. 2261

The University of Texas Athlete Alumni are in absolute opposition of racism in any form and are engaged in meaningful collaboration to enact change. We are united in our support for current student athletes.#UTXAA#ITooAmTexas#BurntOut#WeAreOne pic.twitter.com/B9HTMJ0hde— Fozzy Whittaker (@FozzyWhitt) June 16, 2020 324

The Ventura County Medical Examiner has ruled "Glee" star Naya Rivera's cause of death as an accidental drowning.Rivera's body was recovered from Lake Piru in Ventura County on Monday. On Tuesday, the medical examiner was able to confirm through dental comparison that the body recovered was Rivera's, according to a statement from the medical examiner. 361